(Alzheimer Disease[MAJR]) AND ((Alzheimer disease[TI]) OR (Alzheimer's disease[TI])) AND review[pt] AND english[la] AND human[mh] AND "last 180 days"[dp] - Search Results

Year	Number of Results
2022	4
2023	196
2024	241

1

Gut microbiome-targeted therapies for Alzheimer's disease.

Zhang T, Gao G, Kwok LY, Sun Z. Zhang T, et al. Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7. Gut Microbes. 2023. PMID: 37934614 Free PMC article. Review.

2

Tau-targeting therapies for Alzheimer disease: current status and future directions.

Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM. Congdon EE, et al. Nat Rev Neurol. 2023 Dec;19(12):715-736. doi: 10.1038/s41582-023-00883-2. Epub 2023 Oct 24. Nat Rev Neurol. 2023. PMID: 37875627 Review.

3

Anti-amyloid antibody treatments for Alzheimer's disease.

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C. Perneczky R, et al. Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11. Eur J Neurol. 2024. PMID: 37697714 Free article. Review.

4

Biomarker-based staging of Alzheimer disease: rationale and clinical applications.

Therriault J, Schindler SE, Salvadó G, Pascoal TA, Benedet AL, Ashton NJ, Karikari TK, Apostolova L, Murray ME, Verberk I, Vogel JW, La Joie R, Gauthier S, Teunissen C, Rabinovici GD, Zetterberg H, Bateman RJ, Scheltens P, Blennow K, Sperling R, Hansson O, Jack CR Jr, Rosa-Neto P. Therriault J, et al. Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1. Nat Rev Neurol. 2024. PMID: 38429551 Review.

5

Stimulation of TREM2 with agonistic antibodies-an emerging therapeutic option for Alzheimer's disease.

Schlepckow K, Morenas-Rodríguez E, Hong S, Haass C. Schlepckow K, et al. Lancet Neurol. 2023 Nov;22(11):1048-1060. doi: 10.1016/S1474-4422(23)00247-8. Lancet Neurol. 2023. PMID: 37863592 Review.

6

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease.

Cummings J, Osse AML, Cammann D, Powell J, Chen J. Cummings J, et al. BioDrugs. 2024 Jan;38(1):5-22. doi: 10.1007/s40259-023-00633-2. Epub 2023 Nov 13. BioDrugs. 2024. PMID: 37955845 Free PMC article. Review.

7

The FDA-approved anti-amyloid-beta monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials.

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z. Wu W, et al. Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w. Eur J Med Res. 2023. PMID: 38017568 Free PMC article. Review.

8

Cardiovascular Disease and Alzheimer's Disease: The Heart-Brain Axis.

Saeed A, Lopez O, Cohen A, Reis SE. Saeed A, et al. J Am Heart Assoc. 2023 Nov 7;12(21):e030780. doi: 10.1161/JAHA.123.030780. Epub 2023 Nov 6. J Am Heart Assoc. 2023. PMID: 37929715 Free PMC article. Review.

9

Oxygen metabolism abnormality and Alzheimer's disease: An update.

Liu G, Yang C, Wang X, Chen X, Wang Y, Le W. Liu G, et al. Redox Biol. 2023 Dec;68:102955. doi: 10.1016/j.redox.2023.102955. Epub 2023 Nov 8. Redox Biol. 2023. PMID: 37956598 Free PMC article. Review.

10

Potential Retinal Biomarkers in Alzheimer's Disease.

García-Bermúdez MY, Vohra R, Freude K, Wijngaarden PV, Martin K, Thomsen MS, Aldana BI, Kolko M. García-Bermúdez MY, et al. Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834. Int J Mol Sci. 2023. PMID: 37958816 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

365 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Results by year